Indaptus Therapeutics (INDP) Price/Sales Ratio
Market Cap: $7.54M
Avg Volume: 426.46K
Industry: Biotechnology
Sector: Healthcare
What is Indaptus Therapeutics's Price/Sales Ratio?
- Indaptus Therapeutics's trailing twelve month (TTM) Price/Sales ratio is 0.00.
- Indaptus Therapeutics's annual Price/Sales ratio as of today is 0.00.
- Indaptus Therapeutics's quarterly Price/Sales ratio is 0.00.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess Indaptus Therapeutics's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -0.52
- Quarterly: -0.48
- TTM: -0.29
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 2.00
- Quarterly: 2.00
- TTM: 1.11
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -0.64
- Quarterly: -2.32
- TTM: -0.36
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: 0.04
- Quarterly: -0.03
- TTM: -0.05
These metrics provide insights into Indaptus Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
0.00
Quarterly Price/Sales Ratio
0.00
TTM Price/Sales Ratio
0.00
Indaptus Therapeutics Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
Indaptus Therapeutics Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2024 | 0.00 | -0.52 | 2.00 | -0.64 | 0.04 |
| 2023 | 0.00 | -0.96 | 1.22 | -1.10 | -0.09 |
| 2022 | 0.00 | -0.87 | 0.49 | -0.92 | 0.07 |
| 2021 | 0.00 | -3.03 | 0.65 | -2.07 | 0.04 |
| 2020 | 0.00 | -1.88 | -28.23 | -2.02 | 0.02 |
| 2019 | 0.00 | -0.35 | 1.46 | -0.58 | -0.37 |
| 2018 | 0.00 | -5.40 | 4.39 | -6.02 | 0.37 |
| 2017 | 0.00 | -3.15 | 1.55 | -4.11 | -0.08 |
| 2016 | 0.00 | -4.88 | 2.87 | -5.44 | -0.18 |
| 2015 | 0.00 | -5.82 | 1.17 | -5.27 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for INDP.